nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—TAP1—seminal vesicle—rectum cancer	0.0299	0.0564	CbGeAlD
Lapatinib—PIK3C2B—seminal vesicle—rectum cancer	0.028	0.053	CbGeAlD
Lapatinib—TAP1—urethra—rectum cancer	0.0236	0.0447	CbGeAlD
Lapatinib—TAP1—mammalian vulva—rectum cancer	0.0225	0.0425	CbGeAlD
Lapatinib—PIK3C2B—urethra—rectum cancer	0.0222	0.042	CbGeAlD
Lapatinib—PIK3C2B—mammalian vulva—rectum cancer	0.0211	0.0399	CbGeAlD
Lapatinib—PI4KB—seminal vesicle—rectum cancer	0.0204	0.0386	CbGeAlD
Lapatinib—ERBB2—epithelium—rectum cancer	0.0189	0.0358	CbGeAlD
Lapatinib—ERBB4—epithelium—rectum cancer	0.0189	0.0358	CbGeAlD
Lapatinib—ERBB2—smooth muscle tissue—rectum cancer	0.0183	0.0345	CbGeAlD
Lapatinib—PIK3C2B—female reproductive system—rectum cancer	0.0181	0.0342	CbGeAlD
Lapatinib—ERBB2—renal system—rectum cancer	0.0176	0.0332	CbGeAlD
Lapatinib—TAP1—vagina—rectum cancer	0.0174	0.0329	CbGeAlD
Lapatinib—PI4KB—smooth muscle tissue—rectum cancer	0.0171	0.0323	CbGeAlD
Lapatinib—PI4KB—renal system—rectum cancer	0.0165	0.0311	CbGeAlD
Lapatinib—PIK3C2B—vagina—rectum cancer	0.0164	0.0309	CbGeAlD
Lapatinib—PI4KB—urethra—rectum cancer	0.0162	0.0306	CbGeAlD
Lapatinib—PI4KB—mammalian vulva—rectum cancer	0.0154	0.0291	CbGeAlD
Lapatinib—ERBB2—female reproductive system—rectum cancer	0.0141	0.0266	CbGeAlD
Lapatinib—ERBB4—female reproductive system—rectum cancer	0.0141	0.0266	CbGeAlD
Lapatinib—EGFR—mammalian vulva—rectum cancer	0.0139	0.0263	CbGeAlD
Lapatinib—PI4KB—female reproductive system—rectum cancer	0.0132	0.0249	CbGeAlD
Lapatinib—ERBB4—vagina—rectum cancer	0.0127	0.0241	CbGeAlD
Lapatinib—PI4KB—vagina—rectum cancer	0.0119	0.0225	CbGeAlD
Lapatinib—TAP1—lymph node—rectum cancer	0.0113	0.0213	CbGeAlD
Lapatinib—PIK3C2B—lymph node—rectum cancer	0.0106	0.02	CbGeAlD
Lapatinib—ERBB2—lymph node—rectum cancer	0.00823	0.0156	CbGeAlD
Lapatinib—PI4KB—lymph node—rectum cancer	0.00771	0.0146	CbGeAlD
Lapatinib—EGFR—lymph node—rectum cancer	0.00698	0.0132	CbGeAlD
Lapatinib—CYP2C8—renal system—rectum cancer	0.00478	0.00903	CbGeAlD
Lapatinib—CYP3A5—renal system—rectum cancer	0.00431	0.00815	CbGeAlD
Lapatinib—CYP2C19—vagina—rectum cancer	0.00396	0.00749	CbGeAlD
Lapatinib—CYP2C8—female reproductive system—rectum cancer	0.00383	0.00723	CbGeAlD
Lapatinib—CYP2C8—vagina—rectum cancer	0.00346	0.00654	CbGeAlD
Lapatinib—CYP3A4—renal system—rectum cancer	0.00324	0.00611	CbGeAlD
Lapatinib—CYP3A5—vagina—rectum cancer	0.00312	0.0059	CbGeAlD
Lapatinib—ABCB1—seminal vesicle—rectum cancer	0.00284	0.00537	CbGeAlD
Lapatinib—CYP3A4—female reproductive system—rectum cancer	0.00259	0.0049	CbGeAlD
Lapatinib—ABCB1—epithelium—rectum cancer	0.00247	0.00467	CbGeAlD
Lapatinib—ABCB1—renal system—rectum cancer	0.00229	0.00433	CbGeAlD
Lapatinib—ABCB1—urethra—rectum cancer	0.00225	0.00425	CbGeAlD
Lapatinib—ABCB1—mammalian vulva—rectum cancer	0.00214	0.00405	CbGeAlD
Lapatinib—ABCB1—female reproductive system—rectum cancer	0.00183	0.00347	CbGeAlD
Lapatinib—ABCB1—vagina—rectum cancer	0.00166	0.00313	CbGeAlD
Lapatinib—ERBB2—Signaling by FGFR in disease—NRAS—rectum cancer	0.00116	0.00247	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—NRAS—rectum cancer	0.00116	0.00245	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—TYMS—rectum cancer	0.00115	0.00245	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—NRAS—rectum cancer	0.00115	0.00245	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling of activated FGFR—KRAS—rectum cancer	0.00115	0.00244	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—NRAS—rectum cancer	0.00115	0.00243	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—NRAS—rectum cancer	0.00115	0.00243	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	0.00115	0.00243	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—NRAS—rectum cancer	0.00114	0.00243	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—NRAS—rectum cancer	0.00114	0.00242	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—NRAS—rectum cancer	0.00114	0.00241	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling of activated FGFR—KRAS—rectum cancer	0.00113	0.0024	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB4—KRAS—rectum cancer	0.00113	0.0024	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—NRAS—rectum cancer	0.00113	0.00239	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—NRAS—rectum cancer	0.00112	0.00238	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB4—KRAS—rectum cancer	0.00111	0.00237	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—TYMS—rectum cancer	0.00111	0.00237	CbGpPWpGaD
Lapatinib—EGFR—ErbB Signaling Pathway—TP53—rectum cancer	0.00111	0.00236	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signal transduction—KRAS—rectum cancer	0.00108	0.00229	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—NRAS—rectum cancer	0.00108	0.00229	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR—KRAS—rectum cancer	0.00108	0.00228	CbGpPWpGaD
Lapatinib—ERBB2—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	0.00108	0.00228	CbGpPWpGaD
Lapatinib—ABCB1—lymph node—rectum cancer	0.00107	0.00203	CbGeAlD
Lapatinib—ERBB2—Signaling by ERBB2—KRAS—rectum cancer	0.00107	0.00227	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 signaling—KRAS—rectum cancer	0.00106	0.00226	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signal transduction—KRAS—rectum cancer	0.00106	0.00226	CbGpPWpGaD
Lapatinib—EGFR—ErbB Signaling Pathway—HRAS—rectum cancer	0.00106	0.00226	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—NRAS—rectum cancer	0.00106	0.00225	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR—KRAS—rectum cancer	0.00106	0.00225	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB2—KRAS—rectum cancer	0.00105	0.00224	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—KRAS—rectum cancer	0.00105	0.00224	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	0.00105	0.00223	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—KRAS—rectum cancer	0.00105	0.00223	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—NRAS—rectum cancer	0.00104	0.00221	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	0.00103	0.0022	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.00103	0.00219	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by SCF-KIT—HRAS—rectum cancer	0.00102	0.00217	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.00102	0.00216	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by SCF-KIT—HRAS—rectum cancer	0.00101	0.00214	CbGpPWpGaD
Lapatinib—EGFR—SHP2 signaling—HRAS—rectum cancer	0.001	0.00213	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—KRAS—rectum cancer	0.001	0.00213	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.001	0.00213	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—KRAS—rectum cancer	0.001	0.00213	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—KRAS—rectum cancer	0.000994	0.00211	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—KRAS—rectum cancer	0.000993	0.00211	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—KRAS—rectum cancer	0.000986	0.0021	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.000986	0.0021	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—KRAS—rectum cancer	0.000986	0.0021	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—KRAS—rectum cancer	0.000984	0.00209	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—KRAS—rectum cancer	0.000979	0.00208	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—KRAS—rectum cancer	0.000978	0.00208	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling of activated FGFR—HRAS—rectum cancer	0.000977	0.00208	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—KRAS—rectum cancer	0.000969	0.00206	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—KRAS—rectum cancer	0.000965	0.00205	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling of activated FGFR—HRAS—rectum cancer	0.000962	0.00204	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB4—HRAS—rectum cancer	0.000962	0.00204	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB4—HRAS—rectum cancer	0.000947	0.00201	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000942	0.002	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—rectum cancer	0.000936	0.00199	CbGpPWpGaD
Lapatinib—EGFR—LPA receptor mediated events—HRAS—rectum cancer	0.000929	0.00197	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—KRAS—rectum cancer	0.000927	0.00197	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signal transduction—HRAS—rectum cancer	0.000918	0.00195	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR—HRAS—rectum cancer	0.000914	0.00194	CbGpPWpGaD
Lapatinib—ERBB2—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	0.000914	0.00194	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—KRAS—rectum cancer	0.000913	0.00194	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB2—HRAS—rectum cancer	0.000909	0.00193	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 signaling—HRAS—rectum cancer	0.000905	0.00192	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signal transduction—HRAS—rectum cancer	0.000905	0.00192	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR—HRAS—rectum cancer	0.0009	0.00191	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—KRAS—rectum cancer	0.000896	0.0019	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB2—HRAS—rectum cancer	0.000896	0.0019	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—HRAS—rectum cancer	0.000895	0.0019	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000894	0.0019	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.000892	0.00189	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—HRAS—rectum cancer	0.000891	0.00189	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000887	0.00188	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—ITGA2—rectum cancer	0.000881	0.00187	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.000878	0.00187	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000874	0.00186	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—NRAS—rectum cancer	0.000854	0.00181	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000851	0.00181	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—HRAS—rectum cancer	0.000851	0.00181	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—HRAS—rectum cancer	0.000851	0.00181	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—HRAS—rectum cancer	0.000845	0.0018	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—HRAS—rectum cancer	0.000844	0.00179	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—HRAS—rectum cancer	0.000839	0.00178	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—HRAS—rectum cancer	0.000839	0.00178	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000839	0.00178	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000838	0.00178	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.000836	0.00178	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—HRAS—rectum cancer	0.000833	0.00177	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—HRAS—rectum cancer	0.000831	0.00177	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.000824	0.00175	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—HRAS—rectum cancer	0.00082	0.00174	CbGpPWpGaD
Lapatinib—ERBB2—Focal Adhesion—HRAS—rectum cancer	0.000804	0.00171	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—TP53—rectum cancer	0.000796	0.00169	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—NRAS—rectum cancer	0.000793	0.00168	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—HRAS—rectum cancer	0.000788	0.00167	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—NRAS—rectum cancer	0.000781	0.00166	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—HRAS—rectum cancer	0.000776	0.00165	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—HRAS—rectum cancer	0.000762	0.00162	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000754	0.0016	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000743	0.00158	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—KRAS—rectum cancer	0.000735	0.00156	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—NRAS—rectum cancer	0.000717	0.00152	CbGpPWpGaD
Lapatinib—TAP1—Immune System—NRAS—rectum cancer	0.000701	0.00149	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—KRAS—rectum cancer	0.000682	0.00145	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—NRAS—rectum cancer	0.000675	0.00143	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—KRAS—rectum cancer	0.000672	0.00143	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—NRAS—rectum cancer	0.000646	0.00137	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—NRAS—rectum cancer	0.000646	0.00137	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—NRAS—rectum cancer	0.000635	0.00135	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—HRAS—rectum cancer	0.000625	0.00133	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—KRAS—rectum cancer	0.000617	0.00131	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.000616	0.00131	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—NRAS—rectum cancer	0.000607	0.00129	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—NRAS—rectum cancer	0.000604	0.00128	CbGpPWpGaD
Lapatinib—TAP1—Immune System—KRAS—rectum cancer	0.000603	0.00128	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—NRAS—rectum cancer	0.000601	0.00128	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—NRAS—rectum cancer	0.000598	0.00127	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TP53—rectum cancer	0.000595	0.00126	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NRAS—rectum cancer	0.000589	0.00125	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—NRAS—rectum cancer	0.000587	0.00125	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—KRAS—rectum cancer	0.000581	0.00123	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—HRAS—rectum cancer	0.00058	0.00123	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—HRAS—rectum cancer	0.000571	0.00121	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—NRAS—rectum cancer	0.000563	0.00119	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—NRAS—rectum cancer	0.000563	0.00119	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	0.000563	0.00119	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—NRAS—rectum cancer	0.000557	0.00118	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—KRAS—rectum cancer	0.000556	0.00118	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—KRAS—rectum cancer	0.000556	0.00118	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—NRAS—rectum cancer	0.000553	0.00117	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—NRAS—rectum cancer	0.00055	0.00117	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—KRAS—rectum cancer	0.00055	0.00117	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—KRAS—rectum cancer	0.000547	0.00116	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—HRAS—rectum cancer	0.000525	0.00111	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—KRAS—rectum cancer	0.000522	0.00111	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—NRAS—rectum cancer	0.000521	0.00111	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—KRAS—rectum cancer	0.00052	0.0011	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	0.00052	0.0011	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—rectum cancer	0.000519	0.0011	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—KRAS—rectum cancer	0.000517	0.0011	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—KRAS—rectum cancer	0.000515	0.00109	CbGpPWpGaD
Lapatinib—TAP1—Immune System—HRAS—rectum cancer	0.000513	0.00109	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—NRAS—rectum cancer	0.000512	0.00109	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	0.000507	0.00108	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—KRAS—rectum cancer	0.000505	0.00107	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.000498	0.00106	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—HRAS—rectum cancer	0.000494	0.00105	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—rectum cancer	0.000489	0.00104	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—KRAS—rectum cancer	0.000484	0.00103	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.000484	0.00103	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—KRAS—rectum cancer	0.000484	0.00103	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—rectum cancer	0.000481	0.00102	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—KRAS—rectum cancer	0.00048	0.00102	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—KRAS—rectum cancer	0.000476	0.00101	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—KRAS—rectum cancer	0.000473	0.00101	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—HRAS—rectum cancer	0.000472	0.001	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—HRAS—rectum cancer	0.000465	0.000987	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000456	0.000968	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—NRAS—rectum cancer	0.000452	0.00096	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—rectum cancer	0.000449	0.000953	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—KRAS—rectum cancer	0.000448	0.000952	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—NRAS—rectum cancer	0.000445	0.000946	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—HRAS—rectum cancer	0.000444	0.000943	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—HRAS—rectum cancer	0.000442	0.000938	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	0.000442	0.000938	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—KRAS—rectum cancer	0.000441	0.000936	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—HRAS—rectum cancer	0.00044	0.000934	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—HRAS—rectum cancer	0.000437	0.000929	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—NRAS—rectum cancer	0.000434	0.000922	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.000431	0.000916	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000429	0.000911	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—NRAS—rectum cancer	0.000428	0.000908	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—rectum cancer	0.000414	0.00088	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—HRAS—rectum cancer	0.000412	0.000874	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—HRAS—rectum cancer	0.000412	0.000874	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000412	0.000874	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—HRAS—rectum cancer	0.000408	0.000866	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000405	0.00086	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.000404	0.000859	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—HRAS—rectum cancer	0.000402	0.000855	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—KRAS—rectum cancer	0.000389	0.000827	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—HRAS—rectum cancer	0.000389	0.000826	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—KRAS—rectum cancer	0.000383	0.000814	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—NRAS—rectum cancer	0.000383	0.000814	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—HRAS—rectum cancer	0.000381	0.000809	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—HRAS—rectum cancer	0.000375	0.000795	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—KRAS—rectum cancer	0.000374	0.000794	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—KRAS—rectum cancer	0.000368	0.000782	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000364	0.000774	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—rectum cancer	0.000352	0.000748	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—NRAS—rectum cancer	0.000347	0.000737	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—HRAS—rectum cancer	0.000331	0.000703	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—KRAS—rectum cancer	0.00033	0.000701	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—HRAS—rectum cancer	0.000326	0.000692	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HRAS—rectum cancer	0.000318	0.000675	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HRAS—rectum cancer	0.000313	0.000665	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—KRAS—rectum cancer	0.000298	0.000634	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—HRAS—rectum cancer	0.00028	0.000595	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—NRAS—rectum cancer	0.000263	0.000559	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—NRAS—rectum cancer	0.000259	0.000551	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—HRAS—rectum cancer	0.000254	0.000539	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—NRAS—rectum cancer	0.000247	0.000526	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NRAS—rectum cancer	0.000243	0.000516	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NRAS—rectum cancer	0.000239	0.000509	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.00023	0.000488	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—KRAS—rectum cancer	0.000227	0.000481	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—KRAS—rectum cancer	0.000223	0.000474	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—NRAS—rectum cancer	0.000219	0.000464	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—KRAS—rectum cancer	0.000213	0.000452	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—NRAS—rectum cancer	0.00021	0.000446	CbGpPWpGaD
Lapatinib—ERBB2—Disease—KRAS—rectum cancer	0.000209	0.000444	CbGpPWpGaD
Lapatinib—ERBB4—Disease—KRAS—rectum cancer	0.000206	0.000438	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000204	0.000434	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HRAS—rectum cancer	0.000193	0.000409	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HRAS—rectum cancer	0.00019	0.000403	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—KRAS—rectum cancer	0.000188	0.0004	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—HRAS—rectum cancer	0.000181	0.000385	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—KRAS—rectum cancer	0.000181	0.000384	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HRAS—rectum cancer	0.000178	0.000378	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HRAS—rectum cancer	0.000175	0.000372	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NRAS—rectum cancer	0.00017	0.000362	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NRAS—rectum cancer	0.000168	0.000356	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—HRAS—rectum cancer	0.00016	0.00034	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HRAS—rectum cancer	0.000154	0.000326	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TYMS—rectum cancer	0.000152	0.000323	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KRAS—rectum cancer	0.000147	0.000311	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KRAS—rectum cancer	0.000144	0.000307	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—NRAS—rectum cancer	0.000139	0.000296	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TYMS—rectum cancer	0.000132	0.000279	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—rectum cancer	0.00013	0.000277	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—rectum cancer	0.000128	0.000272	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NRAS—rectum cancer	0.000127	0.00027	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HRAS—rectum cancer	0.000125	0.000265	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HRAS—rectum cancer	0.000123	0.000261	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—KRAS—rectum cancer	0.00012	0.000255	CbGpPWpGaD
Lapatinib—EGFR—Disease—NRAS—rectum cancer	0.000118	0.00025	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TYMS—rectum cancer	0.000117	0.000249	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TYMS—rectum cancer	0.000115	0.000243	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KRAS—rectum cancer	0.00011	0.000233	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HRAS—rectum cancer	0.000102	0.000217	CbGpPWpGaD
Lapatinib—EGFR—Disease—KRAS—rectum cancer	0.000101	0.000215	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HRAS—rectum cancer	9.31e-05	0.000198	CbGpPWpGaD
Lapatinib—EGFR—Disease—HRAS—rectum cancer	8.6e-05	0.000183	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NRAS—rectum cancer	8.23e-05	0.000175	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KRAS—rectum cancer	7.08e-05	0.00015	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TYMS—rectum cancer	7.06e-05	0.00015	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—rectum cancer	6.3e-05	0.000134	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HRAS—rectum cancer	6.02e-05	0.000128	CbGpPWpGaD
